R. Ratner
Diabetes Care · 2004–2016
A researcher in the Science corpus: 10 papers; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Whom R. Ratner trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts R. Ratner overall
Papers from R. Ratner's perspective
Ordered by how strongly the researchers R. Ratner trusts endorse each paper. Same corpus, a different order for every researcher.
- Longitudinal data analysis using generalized linear models
- Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. (Journal of the American Medical Association (JAMA))
- Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. (Diabetes Care)
- Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. (Diabetes Care)
- Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. (New England Journal of Medicine)
- 10-year follow-up of intensive glucose control in type 2 diabetes. (New England Journal of Medicine)
- Biostatistical Methods: The Assessment of Relative Risks
- NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. (Diabetes)
- Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. (Diabetes Care)
- Type 1 diabetes: new perspectives on disease pathogenesis and treatment. (The Lancet)
Their papers
- Pioglitazone for diabetes prevention in impaired glucose tolerance. (2011) — 716 citations
- Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. (2005) — 1,627 citations
- The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial (2005) — 998 citations
- Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis (2016) — 707 citations
- Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association (2015) — 976 citations
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference (2014) — 1,110 citations
- Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial. (2009) — 1,136 citations
- Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. (2009) — 850 citations
- Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. (2008) — 847 citations
- Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. (2004) — 862 citations